CORE LABORATORIES INC (CLB) Forecast, Price Target & Analyst Ratings

NYSE:CLB • US21867A1051

Current stock price

16.92 USD
+0.71 (+4.38%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CORE LABORATORIES INC (CLB).

Forecast Snapshot

Consensus Price Target

Price Target
$16.15
-4.55% Downside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q1 / 2026
EPS Estimate
$0.14
Revenue Estimate
129.57M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
48.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$16.15
Upside
-4.55%
From current price of $16.92 to mean target of $16.15, Based on 10 analyst forecasts
Low
$11.62
Median
$14.28
High
$23.10

Price Target Revisions

1 Month
0.00%
3 Months
3.26%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for CLB. The average price target is 16.15 USD. This implies a price decrease of -4.55% is expected in the next year compared to the current price of 16.92.
The average price target has been revised upward by 3.26% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CLB Current Analyst RatingCLB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

CLB Historical Analyst RatingsCLB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10

Analyst Ratings Consensus

ChartMill Buy Consensus
48.00%
CLB was analyzed by 10 analysts. The buy percentage consensus is at 48. So analysts seem to be rather neutral about CLB.
In the previous month the buy percentage consensus was at a similar level.
CLB was analyzed by 10 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-07-16StifelMaintains Hold -> Hold
2025-05-13CitigroupMaintains Neutral -> Neutral
2025-04-15StifelMaintains Hold -> Hold
2025-03-12CitigroupUpgrade Sell -> Neutral
2025-02-20CitigroupMaintains Sell -> Sell
2024-10-31CitigroupMaintains Sell -> Sell
2024-07-26StifelMaintains Hold -> Hold
2024-07-15B of A SecuritiesMaintains Underperform -> Underperform
2024-07-15Piper SandlerMaintains Neutral -> Neutral
2024-04-26StifelMaintains Hold -> Hold
2024-04-15B of A SecuritiesMaintains Underperform -> Underperform
2024-02-05StifelMaintains Hold -> Hold
2024-01-29StifelMaintains Hold -> Hold
2023-09-18CitigroupMaintains Sell -> Sell
2023-07-31Piper SandlerMaintains Neutral -> Neutral
2023-06-30CitigroupDowngrade Neutral -> Sell
2023-05-01Piper SandlerMaintains Neutral
2023-04-28StifelMaintains Hold
2023-04-18B of A SecuritiesDowngrade Neutral -> Underperform
2023-02-07CitigroupMaintains Neutral
2023-01-09B of A SecuritiesUpgrade Underperform -> Neutral
2022-10-07CitigroupUpgrade Sell -> Neutral
2022-09-26Morgan StanleyDowngrade Equal-Weight -> Underweight
2022-08-01Morgan StanleyMaintains Equal-Weight
2022-07-13Morgan StanleyMaintains Equal-Weight

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q1 / 2026
EPS Estimate
$0.14
Revenue Estimate
129.57M
Revenue Q2Q
4.84%
EPS Q2Q
-0.44%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
-0.72%
EPS (3 Months)
31.43%

Next Earnings Summary

The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2032

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
CLB revenue by date.CLB revenue by date.
509.79M
4.10%		523.848M
2.76%		526.52M
0.51%		519.89M
-1.26%		516.86M
-0.58%		614.08M
18.81%		632.26M
2.96%		650.44M
2.88%		667.61M
2.64%		684.78M
2.57%
EBITDA
YoY % growth
CLB ebitda by date.CLB ebitda by date.
73.144M
19.52%		75.721M
3.52%		71.117M
-6.08%		78.872M
10.90%		74.883M
-5.06%		133.32M
78.04%		148.47M
11.36%		168.67M
13.61%		183.82M
8.98%		191.9M
4.40%
EBIT
YoY % growth
CLB ebit by date.CLB ebit by date.
57.36M
30.36%		60.768M
5.94%		56.468M
-7.08%		58.876M
4.26%		66.67M
13.24%		97.97M
46.95%		112.11M
14.43%		132.31M
18.02%		147.46M
11.45%		154.53M
4.79%
Operating Margin
CLB operating margin by date.CLB operating margin by date.
11.25%11.60%10.72%11.32%12.90%15.95%17.73%20.34%22.09%22.57%
EPS
YoY % growth
CLB eps by date.CLB eps by date.
0.81
39.66%		0.88
8.64%		0.76
-13.64%		0.75
-0.77%		0.80
5.93%		1.36
70.67%		1.61
17.78%		1.93
20.13%		2.17
12.57%		2.29
5.58%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		0.14
-0.44%		0.19
-0.59%		0.22
0.77%		0.22
4.37%		0.14
2.90%		0.20
5.88%		0.23
3.87%		0.23
2.76%
Revenue
Q2Q % growth		129.57M
4.84%		133.61M
2.65%		136.96M
1.81%		144.43M
4.47%		N/AN/AN/AN/A
EBITDA
Q2Q % growth		15.348M
32.64%		18.27M
-18.68%		20.064M
-37.53%		19.882M
-34.77%		15.134M
-1.39%		18.746M
2.61%		20.651M
2.93%		20.354M
2.37%
EBIT
Q2Q % growth		12.08M
53.81%		14.635M
-2.96%		16.392M
-22.45%		18.18M
14.83%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CLB Yearly Revenue VS EstimatesCLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
CLB Yearly EPS VS EstimatesCLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1 2 3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
21.51%
EPS Next 5 Year
20.48%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
5.44%
Revenue Next 5 Year
4.42%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
31.20%
EBIT Next 5 Year
23.36%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

CORE LABORATORIES INC / CLB Forecast FAQ

Can you provide the average price target for CORE LABORATORIES INC stock?

10 analysts have analysed CLB and the average price target is 16.15 USD. This implies a price decrease of -4.55% is expected in the next year compared to the current price of 16.92.

Can you provide the consensus estimates for CORE LABORATORIES INC next earnings?

The consensus EPS estimate for the next earnings of CORE LABORATORIES INC (CLB) is 0.14 USD and the consensus revenue estimate is 129.57M USD.

What is the consensus rating for CORE LABORATORIES INC (CLB) stock?

The consensus rating for CORE LABORATORIES INC (CLB) is 48 / 100 . This indicates that analysts generally have a neutral outlook on the stock.